Edition:
India

Auris Medical Holding AG (EARS.OQ)

EARS.OQ on NASDAQ Stock Exchange Capital Market

0.40USD
10:37pm IST
Change (% chg)

$-0.02 (-4.58%)
Prev Close
$0.42
Open
$0.41
Day's High
$0.41
Day's Low
$0.40
Volume
26,961
Avg. Vol
100,509
52-wk High
$1.39
52-wk Low
$0.38

Chart for

About

Auris Medical Holding AG is a holding and clinical-stage biopharmaceutical company focused on the development of products for the treatment of inner ear disorders. Its advanced product candidate, AM-101, is in Phase III clinical development for acute inner ear tinnitus under a special protocol assessment (SPA) from the United... (more)

Overall

Beta: --
Market Cap(Mil.): $32.28
Shares Outstanding(Mil.): 34.33
Dividend: --
Yield (%): --

Financials

UPDATE 2-Auris Medical shares plunge as deafness drug trial scrapped

* Shares plummet >50 pct to $0.38 (Adds background, details on Auris' pipeline; updates shares)

28 Nov 2017

BRIEF-Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness

* AURIS MEDICAL HOLDING AG SAYS ANNOUNCED TOP-LINE RESULTS FROM THE HEALOS PHASE 3 CLINICAL TRIAL OF AM-111 IN SEVERE TO PROFOUND SUDDEN DEAFNESS

28 Nov 2017

Auris Medical to abandon hearing-loss drug trial

Nov 28 Auris Medical Holding AG said on Tuesday it would terminate a late-stage study testing its drug to treat sudden deafness after the company's lead drug failed to improve hearing ability in patients in another study.

28 Nov 2017

BRIEF-Auris Medical Reports Q3 Loss Per Share CHF 0.14

* AURIS MEDICAL REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

28 Nov 2017

BRIEF-Auris Medical Holding AG files for resale of up to 7.2 mln common shares

* Auris Medical Holding AG files for resale of up to 7.2 million common shares by selling shareholder, LPC Capital Fund Llc‍​ - SEC Filing Source text: (http://bit.ly/2ggfWjL) Further company coverage:

13 Oct 2017

BRIEF-Auris Medical announces share purchase agreements with Lincoln Park Capital Fund

* Auris Medical announces share purchase agreements with Lincoln Park Capital Fund, Llc

11 Oct 2017

BRIEF-Auris Medical announces transfer to Nasdaq capital market

* Auris Medical Holding AG - co's shares will continue to trade uninterrupted under symbol "EARS."​

28 Sep 2017

BRIEF-Auris Medical provides board of directors update

* Auris Medical Holding Ag - ‍announced resignation of antoine papiernik as a member of board of directors due to disagreement with board​

26 Sep 2017

BRIEF-Auris Medical completes patient recruitment for phase 3 trial of Keyzilen in acute and post-acute tinnitus

* Auris Medical completes patient recruitment for phase 3 TACTT3 trial of Keyzilen in acute and post-acute tinnitus

22 Sep 2017

BRIEF-Auris Medical posts Q2 loss per share CHF 0.12

* Auris Medical provides business update and reports second quarter 2017 financial results

10 Aug 2017

Earnings vs. Estimates